Glucagon-like peptide 1 receptor agonists for type 2 diabetes

D Hinnen - Diabetes spectrum, 2017 - Am Diabetes Assoc
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …
被引用次数：327 相关文章

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

D Hinnen - Diabetes spectrum: a publication of the …, 2017 - pubmed.ncbi.nlm.nih.gov
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

D Hinnen - Diabetes Spectrum, 2017 - cir.nii.ac.jp
抄録< jats: p> The incretin system has become an important target in the treatment of type 2
diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its …

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes.

D Hinnen - Diabetes Spectrum: a Publication of the American …, 2017 - europepmc.org
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …
[HTML] nih.gov

[HTML][HTML] Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

D Hinnen - Diabetes Spectrum: A Publication of the American …, 2017 - ncbi.nlm.nih.gov
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes.

D Hinnen - Diabetes Spectrum, 2017 - search.ebscohost.com
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes.

D Hinnen - Diabetes Spectrum: a Publication of the American …, 2017 - europepmc.org
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …